Brainomix
Latest round
- Series C
Last raised
- Feb 2026
Total raised
- $51M
Investors
- 8
About Brainomix
Brainomix Limited, founded in 2010 and headquartered in Oxford, UK, specializes in AI imaging solutions to improve healthcare. The company was co-founded by Andrew Barker, Constantin Thiopoulos, Med Grunwald, Michael Printzos, and Michalis Papadakis, who currently serves as CEO. Brainomix specializes in the development of AI-powered imaging solutions aimed at enhancing clinical decision-making and patient outcomes in various therapeutic areas, primarily focused on stroke, interstitial lung disease (ILD), and solid tumors. The company's flagship product, the Brainomix 360 Stroke platform, automates validated imaging biomarkers to facilitate rapid and accurate stroke assessment, allowing healthcare providers to make informed treatment decisions. Additionally, Brainomix offers the e-Lung platform, designed for the assessment of ILD, and a solid tumor assessment solution, which includes a comprehensive set of classifiers and biomarkers tailored for use in clinical trials for conditions like non-small cell lung cancer (NSCLC).Brainomix generates revenue primarily through subscription-based models and partnerships with healthcare institutions and research organizations. Transactions typically involve licensing their AI imaging solutions to hospitals and clinical trial sponsors, enabling them to enhance diagnostic accuracy and treatment planning. The company's offerings, such as the Brainomix 360 Stroke and e-Lung platforms, operate under structured pricing plans that reflect the value of automated imaging capabilities in clinical settings. These partnerships may also include collaborative agreements for joint research and development initiatives, further solidifying Brainomix's position in the healthcare market. The EBITDA for the most recent year, 2022, is reported at GBP 0.S. operations, deploy its Brainomix 360 Stroke and e-Lung platforms across more hospitals, and strengthen customer support and product development.
Who invested in Brainomix
8 investors across 3 rounds
See all investors in Brainomix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Brainomix
Who invested in Brainomix?
Brainomix has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brainomix raised?
Brainomix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Brainomix last raise money?
Brainomix's most recent round on record is a Series C, in Feb 2026.
What does Brainomix do?
Brainomix Limited, founded in 2010 and headquartered in Oxford, UK, specializes in AI imaging solutions to improve healthcare.
Where is Brainomix headquartered?
Brainomix is headquartered in Oxford, UK.
Which VCs invest in companies like Brainomix?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Marktlink Capital back software companies at Brainomix's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Brainomix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.